Article Text

PDF
Research
Device-assisted enteroscopy in the UK: description of a large tertiary case series under conscious sedation
  1. Vijay Pattni,
  2. David J Tate,
  3. Ana Terlevich,
  4. Peter Marden,
  5. Steve Hughes
  1. Department of Gastroenterology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK
  1. Correspondence to Dr Vijay Pattni, Department of Gastroenterology, Southmead Hospital, North Bristol NHS Trust, Bristol, BS10 5NB, UK; vijaypattni{at}hotmail.com

Abstract

Objective Device-assisted enteroscopy (DAE) has developed rapidly, particularly with the advent of double-balloon enteroscopy (DBE). This study reports a case series from a UK tertiary centre for DAE across two modalities—DBE and spiral enteroscopy (SE)—under conscious sedation.

Design Retrospective observational study of 257 enteroscopy procedures from 2008 to 2014. Data were collected on demographics, indications, diagnosis, sedation requirements, duration, complications, tolerance, therapy performed and completion rate. Procedures were performed under conscious sedation using a combination of midazolam, pethidine and fentanyl in a solely outpatient setting.

Results Obscure gastrointestinal bleeding (OGIB) was the commonest indication for DAE (n=164, 63.8%). Overall, yield of DAE was 47.2% and varied significantly across the indications (p=0.003). There was a greater likelihood of positive findings if the indication was polyposis syndrome (75%), abnormal capsule endoscopy (67%) or OGIB (53%) and in older patients (mean age normal exam 60.3 vs abnormal exam 67.9 years, p<0.001). Higher mean doses of midazolam were used for DBE from above (5.4 mg, SD 2.24) and SE (5.6 mg, SD 2.9) to DBE from below (4.4 mg, SD 1.8). No serious complications were recorded. Tolerance of DAE was good with the majority (240/257, 93.4%) of procedures tolerated with comfort scores 0 or 1. Therapy was performed in 121/257 (47.1%) of procedures. The strongest predictor indications for therapy to be performed at DAE were abnormal capsule endoscopy (88.9%) and occult gastrointestinal (GI) bleeding (54.9%). Completion rates were higher in DBEb (91.8%) compared to DBEa (76.5%) and SE (81.6%).

Conclusion DAE under conscious sedation is safe and well tolerated. DAE has a high yield if performed for recognised indications and may be safely used to provide therapy where a diagnosis has been made using other modalities.

  • enteroscopy

Statistics from Altmetric.com

Footnotes

  • Contributors VP, DJT, PM and SH helped in the conception and design of the study. VP collated and organised data from the departmental database. DJT performed statistical analysis of the data, helped write the original manuscript, which was also edited by VP. AT, PM and SH reviewed the final manuscript, which was then further revised by VP. VP submitted the final manuscript and is therefore responsible for the overall content of the submission as a guarantor. VP and DJT contributed equally to the overall study and therefore are denoted as joint first authors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Local ethics approval gained from audit department to access departmental database. Push enteroscopy unpublished data can be accessed by written request by email correspondence to department/authors if needed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.